Literature DB >> 7316727

Investigations on enzyme activity in the serum and CSF of patients with neuromuscular diseases.

P Diószeghy, F Mechler, E Csenkér.   

Abstract

The CPK, aldolase, GOT, GPT, and LDH concentrations in the serum and lumbar CSF of 80 patients with neuromuscular diseases and 20 controls were measured. The value obtained in serum was essentially in agreement with the data in the literature. This is the first publications reporting on regular CSF enzyme examinations in different neuromuscular disorders, particularly the results obtained in neurogenic muscular atrophies, which have certain characteristic features. The LDH activity in CSF was decreased in peroneal muscular atrophy, the GPT concentration in CSF was elevated in spinal muscular atrophy, and the mean activity of CSF aldolase was increased in amyotrophic lateral sclerosis. The simultaneous determination of enzymes in serum and CSF can provide valuable information in the research of certain details of pathomechanisms and thus lead to further improvement of diagnosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7316727     DOI: 10.1007/bf00346102

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  9 in total

1.  SERUM ENZYME STUDIES IN MUSCLE DISEASE. III. SERUM CREATINE KINASE ACTIVITY IN RELATIVES OF PATIENTS WITH THE DUCHENNE TYPE OF MUSCULAR DYSTROPHY.

Authors:  J M PEARCE; R J PENNINGTON; J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-06       Impact factor: 10.154

2.  Activity of lactic dehydrogenase in spinal fluid.

Authors:  F WROBLEWSKI; B DECKER; R WROBLEWSKI
Journal:  Am J Clin Pathol       Date:  1957-09       Impact factor: 2.493

3.  Serum-creatine-kinase in cases of stroke, head injury, and meningitis.

Authors:  H Dubo; D C Park; R J Pennington; R M Kalbag; J N Walton
Journal:  Lancet       Date:  1967-10-07       Impact factor: 79.321

4.  Serum enzyme alterations in neuromuscular disorders.

Authors:  T L Munsat; R Baloh; C M Pearson; W Fowler
Journal:  JAMA       Date:  1973-12-24       Impact factor: 56.272

5.  Serum creatine phosphokinase in motor neuron disease.

Authors:  K M Welch; D M Goldberg
Journal:  Neurology       Date:  1972-07       Impact factor: 9.910

6.  Creatine phosphokinase in motor neurone disease.

Authors:  E R Williams; A Bruford
Journal:  Clin Chim Acta       Date:  1970-01       Impact factor: 3.786

7.  Serum and cerebrospinal fluid enzymes in cerebrovascular disease. Creatine phosphokinase, aldolase, and lactic dehydrogenase.

Authors:  A H Wolintz; L D Jacobs; N Christoff; M Solomon; N Chernik
Journal:  Arch Neurol       Date:  1969-01

8.  Creatine phosphokinase levels and cerebral disease.

Authors:  D J Schiavone; J Kaldor
Journal:  Med J Aust       Date:  1965-11-06       Impact factor: 7.738

9.  [Comparative study on quantitative cerebrospinal fluid and urinary protein determination with a modified Exton reagent].

Authors:  K Gernand; E Hajek
Journal:  Dtsch Gesundheitsw       Date:  1966-03-17
  9 in total
  1 in total

1.  Swim Training Modulates Skeletal Muscle Energy Metabolism, Oxidative Stress, and Mitochondrial Cholesterol Content in Amyotrophic Lateral Sclerosis Mice.

Authors:  Damian Jozef Flis; Katarzyna Dzik; Jan Jacek Kaczor; Malgorzata Halon-Golabek; Jedrzej Antosiewicz; Mariusz Roman Wieckowski; Wieslaw Ziolkowski
Journal:  Oxid Med Cell Longev       Date:  2018-04-11       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.